Psoriasis and Cardiovascular Disease: A Narrative Review
- Author:
Adrian MARTINEZ-MORENO
1
;
Jorge OCAMPO-CANDIANI
;
Veronica GARZA-RODRIGUEZ
Author Information
- Publication Type:Review Article
- From:Korean Journal of Family Medicine 2021;42(5):345-355
- CountryRepublic of Korea
- Language:English
- Abstract: Psoriasis is a chronic, autoimmune, and inflammatory disease that affects 2% of the world’s population. In recent years, it has been demonstrated that psoriasis confers a 25% increase in relative risk of cardiovascular disease, independent of factors such as hyperlipidemia, smoking, and obesity. The objective of this review was to analyze and describe the association between psoriasis and cardiovascular disease. In this review, we describe the epidemiological association of psoriasis and cardiovascular disease, pathophysiology, mechanisms, and its association with the well-known cardiovascular risk calculators. In addition, we describe diagnostic tools, such as imaging techniques and novel biomarkers, that are useful in the evaluation of atherosclerotic cardiovascular disease. Finally, we present different systemic therapies that are used in patients with psoriasis and their effect on atherosclerotic cardiovascular disease. This article provides an overview of the current literature on psoriasis and cardiovascular risk, which can be useful for primary care physicians in their daily clinical practice.
